Thomas Jefferson University joins TriNetX research network

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THOMAS JEFFERSON UNIVERSITY joined the TriNetX network for clinical trial design and to support Jefferson’s clinical research programs.

Pharmaceutical researchers will be able to access Jefferson’s de-identified clinical data through TriNetX’s network of healthcare institutions to support clinical study and protocol design, site selection, and patient recruitment across a range of therapeutic areas and development stages.

YOU MAY BE INTERESTED IN

Login